Cases & Deals

  • Home
  • Practices
  • Inmagene Biopharmaceuticals grants global rights to develop, manufacture, and commercialize antibody therapeutic candidates

Share

Inmagene Biopharmaceuticals grants global rights to develop, manufacture, and commercialize antibody therapeutic candidates

January 2025

Client(s) Inmagene Biopharmaceuticals

Jones Day advised Inmagene Biopharmaceuticals on granting global rights for collaborations with multiple partners to develop, manufacture, and commercialize antibody therapeutic candidates.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.